Azerbaijan vs South Africa: Estimated antiretroviral therapy coverage among people living with HIV
Azerbaijan
81.0%
in 2025
South Africa
81.0%
in 2025
Azerbaijan rank
49th
South Africa rank
49th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Azerbaijan
- South Africa
How they compare
Azerbaijan currently reports 81.0% against 81.0% in South Africa, a difference of 0.0%.
Across all 25 years both countries report, South Africa has been ahead every year.
Azerbaijan ranks 49th and South Africa ranks 49th of 143 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.6% | 5.9% | 5.3% | South Africa |
| 2010s | 20.9% | 52.9% | 32.0% | South Africa |
| 2020s | 62.3% | 80.2% | 17.8% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Azerbaijan or South Africa?
- Azerbaijan, at 81.0% against 81.0% in South Africa as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Azerbaijan and South Africa?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and South Africa?
- 25 years are reported by both, from 2000 to 2025.
- How do Azerbaijan and South Africa rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Azerbaijan ranks 49th and South Africa ranks 49th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.